Radiotherapy as effective as surgery for prostate cancer

Researchers announced that radiotherapy can match surgery for localized prostate cancer, a finding first reported by The Independent. The claim that the treatment is 'as effective as' surgery was also echoed by The Telegraph, signalling a shift in perceived therapeutic parity. Urology Times detailed that the PACE‑A trial compared stereotactic body radiotherapy (SBRT) with prostatectomy and observed comparable long‑term disease control, underscoring durability of the radiation approach.

Medical Xpress highlighted that the SBRT protocol was delivered in just five treatment sessions, presenting an effective nonsurgical alternative that reduces patient burden. News‑Medical added that emerging insights into prostate cancer biology are being leveraged to identify patients who might benefit from adjunct hormone therapy, integrating systemic options with radiation. The Independent and The Telegraph present the equivalence in absolute terms, while Urology Times frames the result as comparable, introducing a subtle nuance but no direct conflict.

Collectively, the coverage positions radiotherapy as a credible alternative to surgical removal, suggesting that clinicians may increasingly consider nonsurgical options for patients with localized disease.